Diffusion Pharmaceuticals - DFFN
| Total Followers: | 0 |
|
|
|
| Follow | |
Latest DFFN News
- EIP Pharma and Diffusion Pharmaceuticals Announce Merger Agreement to Create Leading CNS-focused Company Treating Neurodegenerative Diseases - GlobeNewswire Inc. - Thu, Mar 30, 2023 11:00 AM
- Diffusion Pharmaceuticals Announces Agreement with LifeSci Special Opportunities - GlobeNewswire Inc. - Fri, Dec 16, 2022 11:30 AM
- Diffusion Pharmaceuticals Sends Letter to Stockholders Highlighting Strength of Board Leadership and Positive Progress in Strategic Review, Cautioning Stockholders Regarding LifeSci’s History of Stockholder Value Destruction and Self-Dealing - GlobeNewswire Inc. - Mon, Dec 5, 2022 11:30 AM
- Diffusion Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Business Update - GlobeNewswire Inc. - Mon, Nov 14, 2022 9:01 PM
- Diffusion Pharmaceuticals Sees Significant Progress in its Strategic Review Process - GlobeNewswire Inc. - Mon, Nov 14, 2022 11:30 AM
- Diffusion Pharmaceuticals Announces Strategic Review Process to Evaluate Value-Enhancing Alternatives including Opportunities to Better Leverage TSC - GlobeNewswire Inc. - Tue, Oct 25, 2022 10:30 AM
- Benzinga's Top Ratings Upgrades, Downgrades For August 16, 2022 - Benzinga - Tue, Aug 16, 2022 2:12 PM
- Diffusion Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Business Update - GlobeNewswire Inc. - Thu, Aug 11, 2022 10:48 PM
- Diffusion Pharmaceuticals Announces Positive Effects in Altitude Trial - GlobeNewswire Inc. - Thu, Jun 23, 2022 11:30 AM
- Diffusion Pharmaceuticals Regains Compliance With Nasdaq Listing Requirements - GlobeNewswire Inc. - Wed, May 4, 2022 11:20 AM
Link Copied to Clipboard!